SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5.99 |
| Enterprise Value ($M) | 71.03 |
| Book Value ($M) | 77.86 |
| Book Value / Share | 38.45 |
| Price / Book | 0.08 |
| NCAV ($M) | -5.78 |
| NCAV / Share | -2.85 |
| Price / NCAV | -1.04 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.07 |
| Return on Assets (ROA) | -1.11 |
| Return on Equity (ROE) | -2.27 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.21 |
| Current Ratio | 1.21 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.49 |
| Assets | 91.13 |
| Liabilities | 13.27 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -15.77 |
| Net Income | -15.79 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -12.38 |
| Cash from Investing | -0.50 |
| Cash from Financing | 15.23 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 13,205 | 55,880 | 23.63 | |
| 3,396 | 43,412 | 7.82 | |
| 6,060 | 38,268 | 15.84 | |
| 2,141 | 19,354 | 11.06 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FENC – Fennec Pharmaceuticals Inc. | FLGC – Flora Growth Corp. |
| FTLF – FitLife Brands, Inc. | GALT – Galectin Therapeutics Inc. |
| GDTC – CytoMed Therapeutics Limited |
Financial data and stock pages provided by
Fintel.io